These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16594638)

  • 1. Shear-induced variability in the United States Pharmacopeia Apparatus 2: modifications to the existing system.
    Baxter JL; Kukura J; Muzzio FJ
    AAPS J; 2006 Jan; 7(4):E857-64. PubMed ID: 16594638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D hydrodynamics and shear rates' variability in the United States Pharmacopeia Paddle Dissolution Apparatus.
    Ameur H; Bouzit M
    Int J Pharm; 2013 Aug; 452(1-2):42-51. PubMed ID: 23680733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions.
    Kukura J; Baxter JL; Muzzio FJ
    Int J Pharm; 2004 Jul; 279(1-2):9-17. PubMed ID: 15234789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at different impeller agitation speeds.
    Bai G; Wang Y; Armenante PM
    Int J Pharm; 2011 Jan; 403(1-2):1-14. PubMed ID: 20883758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus.
    McCarthy LG; Kosiol C; Healy AM; Bradley G; Sexton JC; Corrigan OI
    AAPS PharmSciTech; 2003; 4(2):E22. PubMed ID: 12916904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrodynamic investigation of USP dissolution test apparatus II.
    Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
    J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Velocity distribution and shear rate variability resulting from changes in the impeller location in the USP dissolution testing apparatus II.
    Bai G; Armenante PM
    Pharm Res; 2008 Feb; 25(2):320-36. PubMed ID: 18040760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
    Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability.
    D'Arcy DM; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2005 Oct; 57(10):1243-50. PubMed ID: 16259752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
    Bai G; Armenante PM
    J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate, mixing patterns, and fluid velocities.
    McCarthy LG; Bradley G; Sexton JC; Corrigan OI; Healy AM
    AAPS PharmSciTech; 2004 Apr; 5(2):e31. PubMed ID: 15760089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution test acceptance sampling plans.
    Tsong Y; Hammerstrom T; Lin K; Ong TE
    J Biopharm Stat; 1995 Jul; 5(2):171-83. PubMed ID: 7581426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug release from matrix tablets: physiological parameters and the effect of food.
    Nokhodchi A; Asare-Addo K
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1401-18. PubMed ID: 24970101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the effect of solubility and density gradients on local hydrodynamics and drug dissolution in the USP 4 dissolution apparatus.
    D'Arcy DM; Liu B; Corrigan OI
    Int J Pharm; 2011 Oct; 419(1-2):175-85. PubMed ID: 21843609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Donauer N; Löbenberg R
    Int J Pharm; 2007 Dec; 345(1-2):2-8. PubMed ID: 17935916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the continuous fluid exchange system in the USP basket-stirrer dissolution test assembly. Part I: pH-dissolution rate behavior.
    Huynh-Ngoc T; Sirois G
    J Pharm Belg; 1976; 58(6):589-98. PubMed ID: 16109
    [No Abstract]   [Full Text] [Related]  

  • 18. Engineering tools for understanding the hydrodynamics of dissolution tests.
    Kukura J; Arratia PE; Szalai ES; Muzzio FJ
    Drug Dev Ind Pharm; 2003 Feb; 29(2):231-9. PubMed ID: 12648020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications.
    Ngo SN; Barnes T
    Int J Pharm Pract; 2010 Aug; 18(4):245-8. PubMed ID: 20636678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.